Education
About Us
Working with TipRanks
Follow Us
Opko Health Inc (OPK)
NASDAQ:OPK
OPK Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.12 - $2.04
Previous CloseN/A
Volume574.71K
Average Volume (3M)6.60M
Market Cap
$1.21B
Enterprise Value$1.59B
Total Cash (Recent Filing)$431.94M
Total Debt (Recent Filing)$504.44M
Price to Earnings (P/E)―
Beta0.96
Next Earnings
May 13, 2025EPS Estimate
-0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding671,550,300
10 Day Avg. Volume3,388,640
30 Day Avg. Volume6,601,466
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.70
Price to Cash Flow (P/CF)-1.20
P/FCF Ratio0.00
Enterprise Value/Market Cap1.32
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit5.12
Enterprise Value/Ebitda11.78
Forecast
1Y Price Target
$2.42Price Target Upside39.08% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
---
Bulls Say, Bears Say
Bulls Say
Asset SalesThe asset sale to LH provides OPK with an upfront payment of $192.5 million, which is expected to significantly increase the company's cash reserves.
Financial PerformanceOPKO Health reported a top- and bottom-line beat in its 4Q24 financial results, with total revenue exceeding projections.
Strategic PartnershipsOPKO Health and Entera Bio have entered into a collaboration to advance the first oral dual agonist GLP-1/glucagon peptide as a once-daily tablet treatment for obesity and other disorders.
Bears Say
Diagnostics ServicesRisks include lower-than-projected growth of diagnostics services and inability to develop and secure regulatory approval for novel pharmaceuticals.
Revenue DeclineDiagnostics services revenue declined by 17% year-over-year due to lower clinical test volume, primarily from the sale of BioReference assets.
---
Ownership Overview
52.21% Insiders
6.46% Mutual Funds
9.40% Other Institutional Investors
21.30% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
OPK FAQ
What was Opko Health Inc’s price range in the past 12 months?
Opko Health Inc lowest stock price was $1.12 and its highest was $2.04 in the past 12 months.
What is Opko Health Inc’s market cap?
Opko Health Inc’s market cap is $1.21B.
When is Opko Health Inc’s upcoming earnings report date?
Opko Health Inc’s upcoming earnings report date is May 13, 2025 which is in 45 days.
How were Opko Health Inc’s earnings last quarter?
Opko Health Inc released its earnings results on Feb 27, 2025. The company reported $0.01 earnings per share for the quarter, beating the consensus estimate of -$0.093 by $0.103.
Is Opko Health Inc overvalued?
According to Wall Street analysts Opko Health Inc’s price is currently Undervalued.
Does Opko Health Inc pay dividends?
Opko Health Inc does not currently pay dividends.
What is Opko Health Inc’s EPS estimate?
Opko Health Inc’s EPS estimate is -0.08.
How many shares outstanding does Opko Health Inc have?
Opko Health Inc has 671,550,300 shares outstanding.
What happened to Opko Health Inc’s price movement after its last earnings report?
Opko Health Inc reported an EPS of $0.01 in its last earnings report, beating expectations of -$0.093. Following the earnings report the stock price went up 6.748%.
Which hedge fund is a major shareholder of Opko Health Inc?
Currently, no hedge funds are holding shares in OPK
---
Opko Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$2.42 (39.08% Upside)
$2.42 (39.08% Upside)
Blogger Sentiment
Bullish
OPK Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 62.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $1.5M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days <0.1%
Last 30 Days ▼ 0.8%
Last 30 Days ▼ 0.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
62.61%
12-Months-Change
Fundamentals
Return on Equity
-3.87%
Trailing 12-Months
Asset Growth
9.37%
Trailing 12-Months
Company Description
Opko Health Inc
OPKO Health, Inc. is a diversified healthcare company that operates in the pharmaceutical, diagnostics, and biologics sectors. The company is engaged in the discovery, development, and commercialization of novel and proprietary technologies and products that aim to improve patient outcomes. OPKO's core offerings include diagnostic solutions, pharmaceuticals, and biologics, with a focus on addressing unmet medical needs in the areas of diagnostics and treatment.
---
OPK Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant advancements in the ModeX pipeline, successful global commercialization efforts for NGENLA, and substantial additional funding from BARDA for antiviral programs. However, these positive developments were tempered by a decline in Diagnostics segment revenue and operating losses, as well as increased R&D expenses and foreign currency challenges. Overall, the highlights slightly outweigh the lowlights.Read More>---
OPK Stock 12 Month Forecast
Average Price Target
$2.42
▲(39.08% Upside)
Technical Analysis
Best Analysts Covering OPK
1 Year
1 Year Success Rate
18/39 ratings generated profit
1 Year Average Return
+13.47%
reiterated a buy rating 17 days ago
Copying Michael Petusky's trades and holding each position for 1 Year would result in 46.15% of your transactions generating a profit, with an average return of +13.47% per trade.
---